Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference Transcript
Hello, everyone, and welcome to the fourth annual H.C. Wainwright Neuropsychiatry Virtual Conference. My name is Patrick Trucchio. I'm a senior healthcare analyst at H.C. Wainwright and the host for the conference today. We have a robust agenda for the conference this year with more than 20 companies presenting with their sessions available on demand through the conference portal. In addition, we're expecting a full day of panels and fireside chats on the day of the conference, June 26, with a focus on novel treatments in various mood disorders, along with AI and drug development, payer and commercial considerations, among many other topics.
And with that, it's my pleasure to introduce our next presenter, Robert Barrow, CEO of Mind Medicine, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, starting first with lead candidate MM-120 in generalized anxiety disorder and ADHD.
So maybe we could first start with just talking more about MindMed, if you could give us the history
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
